» Articles » PMID: 19191619

Enhanced Diagnosis of Pneumococcal Meningitis with Use of the Binax NOW Immunochromatographic Test of Streptococcus Pneumoniae Antigen: a Multisite Study

Abstract

Background: Accurate etiological diagnosis of meningitis in developing countries is needed, to improve clinical care and to optimize disease-prevention strategies. Cerebrospinal fluid (CSF) culture and latex agglutination testing are currently the standard diagnostic methods but lack sensitivity.

Methods: We prospectively assessed the utility of an immunochromatographic test (ICT) of pneumococcal antigen (NOW Streptococcus pneumoniae Antigen Test; Binax), compared with culture, in 5 countries that are conducting bacterial meningitis surveillance in Africa and Asia. Most CSF samples were collected from patients aged 1-59 months.

Results: A total of 1173 CSF samples from suspected meningitis cases were included. The ICT results were positive for 68 (99%) of the 69 culture-confirmed pneumococcal meningitis cases and negative for 124 (99%) of 125 culture-confirmed bacterial meningitis cases caused by other pathogens. By use of culture and latex agglutination testing alone, pneumococci were detected in samples from 7.4% of patients in Asia and 15.6% in Africa. The ICT increased pneumococcal detection, resulting in similar identification rates across sites, ranging from 16.2% in Nigeria to 20% in Bangladesh. ICT detection in specimens from culture-negative cases varied according to region (8.5% in Africa vs. 18.8% in Asia; P< .001), prior antibiotic use (24.2% with prior antibiotic use vs. 12.2% without; P< .001), and WBC count (9.0% for WBC count of 10-99 cells/mL, 22.1% for 100-999 cells/mL, and 25.4% for >or=1000 cells/mL; P< .001 by test for trend).

Conclusions: The ICT provided substantial benefit over the latex agglutination test and culture at Asian sites but not at African sites. With the addition of the ICT, the proportion of meningitis cases attributable to pneumococci was determined to be similar in Asia and Africa. These results suggest that previous studies have underestimated the proportion of pediatric bacterial meningitis cases caused by pneumococci.

Citing Articles

Estimating national, regional and provincial cost-effectiveness of introducing childhood 13-valent pneumococcal conjugate vaccination in China: a modelling analysis.

Lai X, Garcia C, Wu D, Knoll M, Zhang H, Xu T Lancet Reg Health West Pac. 2023; 32:100666.

PMID: 36785861 PMC: 9918781. DOI: 10.1016/j.lanwpc.2022.100666.


Integration of Ni/NiO nanoparticles and a microfluidic ELISA chip to generate a sensing platform for detection.

Weng C, Chao C, Wu S, Tsou P, Chen W, Li B RSC Adv. 2022; 11(46):28551-28556.

PMID: 35478579 PMC: 9038132. DOI: 10.1039/d1ra04631d.


Pneumococcal meningitis in adults in 2014-2018 after introduction of pediatric 13-valent pneumococcal conjugate vaccine in Japan.

Chang B, Tamura K, Fujikura H, Watanabe H, Tanabe Y, Kuronuma K Sci Rep. 2022; 12(1):3066.

PMID: 35197497 PMC: 8866494. DOI: 10.1038/s41598-022-06950-w.


Management of Acute Bacterial Meningitis in Children.

Alamarat Z, Hasbun R Infect Drug Resist. 2020; 13:4077-4089.

PMID: 33204125 PMC: 7667001. DOI: 10.2147/IDR.S240162.


Performance of the ImmuView and BinaxNOW assays for the detection of urine and cerebrospinal fluid Streptococcus pneumoniae and Legionella pneumophila serogroup 1 antigen in patients with Legionnaires' disease or pneumococcal pneumonia and meningitis.

Edelstein P, Jorgensen C, Wolf L PLoS One. 2020; 15(8):e0238479.

PMID: 32866217 PMC: 7458278. DOI: 10.1371/journal.pone.0238479.


References
1.
Kamiya H, Uehara S, Kato T, Shiraki K, Togashi T, Morishima T . Childhood bacterial meningitis in Japan. Pediatr Infect Dis J. 1998; 17(9 Suppl):S183-5. DOI: 10.1097/00006454-199809001-00019. View

2.
Samra Z, Shmuely H, Nahum E, Paghis D, Ben-Ari J . Use of the NOW Streptococcus pneumoniae urinary antigen test in cerebrospinal fluid for rapid diagnosis of pneumococcal meningitis. Diagn Microbiol Infect Dis. 2003; 45(4):237-40. DOI: 10.1016/s0732-8893(02)00548-5. View

3.
Campagne G, Schuchat A, Djibo S, Ousseini A, Cisse L, Chippaux J . Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96. Bull World Health Organ. 1999; 77(6):499-508. PMC: 2557688. View

4.
Cowgill K, Ndiritu M, Nyiro J, Slack M, Chiphatsi S, Ismail A . Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA. 2006; 296(6):671-8. PMC: 1592684. DOI: 10.1001/jama.296.6.671. View

5.
Gessner B, Sutanto A, Linehan M, Djelantik I, Fletcher T, Gerudug I . Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet. 2005; 365(9453):43-52. DOI: 10.1016/s0140-6736(04)17664-2. View